144 Turnpike Road, Suite 110, 01772 Southborough, MA
USA
Telephone +1 508 599-2400
http://biodirection.com
Product Categories
Product categories
01 Electromedical Equipment / Medical Technology
01.01 Diagnostics
01.01.06 Neurological diagnosis, apparatus and instruments
Neurological diagnosis, apparatus and instruments
Tbit™ Blood Testing Platform
03 Diagnostic Tests
03.07 Other diagnostics
Other diagnostics
Our products
Product category: Neurological diagnosis, apparatus and instruments
Tbit™ Blood Testing Platform
World’s First Nanowire Biosensing Platform for concussion and other TBI
Delivers objective results in less than 90 seconds, identifying TBI and reducing unnecessary CT scans for concussion.
Point-of-care platform to detect and measure a panel of protein biomarkers released into the bloodstream after a Traumatic Brain Injury.
Unique and proprietary technology that offers:
Ultra-high sensitivity
Quantitative results in < 90 seconds
Single drop of whole blood
Multiplexing on a single cartridge
Easy-to-use, affordable, disposable cartridge
Point-of-care delivery
Adaptability to any biomarker panel
ad: contact information
About Us
Company details
BioDirection, Inc. is a privately-held medical device company developing novel and rapid point-of care products for the objective management of concussion and other traumatic brain injuries (TBI).
Tbit™ System
BioDirection’s first product is called the Tbit™ system. The Tbit™ system is the world’s first multiplexing platform utilizing patented biosensing nanowire technology that can detect and measure very low concentrations of “biomarker” proteins released from the brain after a concussion or other traumatic brain injury.
Objective Diagnosis in 90 Seconds
This breakthrough platform technology delivers objective information to aid in the diagnosis of a concussion from just a single drop of blood in less than 90 seconds. Additionally, this technology provides emergency responders with new actionable data that can help in reducing unnecessary head CT scans, thereby saving time and costs while eliminating unnecessary radiation exposure to the patient.
Intellectual Property
BioDirection holds a large intellectual property portfolio with broad filings in both the U.S. and in key foreign jurisdictions for the use of Nano biosensors in the field of brain injury. The extensive Harvard University generated intellectual property portfolio was invented by Dr. Charles Lieber, a recognized pioneer in the field of Nanowire technology.
ad: company
Bio-Med Devices, Inc.Bio-Techne Corporation
BioAssay Works, LLC
Biomedical Innovations
Biomerica, Inc.
Biometrix Ltd.